BriaCell advances melanoma vaccine candidate to genetic engineering milestone
Go back to BriaCell advances melanoma vaccine candidate to genetic engineering milestone| (NASDAQ: BCTX) | Delayed: 4.15 -0.06 (1.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.21 | 52 Week High | $ | |||
| Open | $4.16 | 52 Week Low | $ | |||
| Day High | $4.22 | P/E | N/A | |||
| Day Low | $4.03 | EPS | $ | |||
| Volume | 167,675 | |||||

